The Journal of the Society of Stroke on Korean Medicine (대한중풍순환신경학회지)

The Society of Stroke on Korean Medicine (대한중풍순환신경학회)
권호 표지

A Case Report of the Beneficial Effects of Chunghyul-Plus in Dyslipidemia Patients

청혈플러스로 호전된 이상지질혈증 환자 4례 보고

  • Jung, Eun Sun (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Kim, Hyun Tae (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Choi, Koh Eun (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Oh, Jeong Min (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Cho, Hyun Kyoung (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Yoo, Ho Ryong (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Kim, Yoon Sik (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University) ;
  • Seol, In Chan (Department of Circulatory Internal Medicine, College of Oriental Medicine, Daejeon University)
  • 정은선 (대전대학교 한의과대학 심계내과학교실) ;
  • 김현태 (대전대학교 한의과대학 심계내과학교실) ;
  • 최고은 (대전대학교 한의과대학 심계내과학교실) ;
  • 오정민 (대전대학교 한의과대학 심계내과학교실) ;
  • 조현경 (대전대학교 한의과대학 심계내과학교실) ;
  • 유호룡 (대전대학교 한의과대학 심계내과학교실) ;
  • 김윤식 (대전대학교 한의과대학 심계내과학교실) ;
  • 설인찬 (대전대학교 한의과대학 심계내과학교실)
  • Published : 2016.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Dyslipidemia is a major risk factor for cardiovascular accidents (CVA) and heart disease, especially the ischemic type. Lowering of serum low-density lipoprotein cholesterol (LDL-C) levels is a primary measure for preventing atherosclerosis. Many medications are available for the treatment of dyslipidemia; however, these drugs have some side effects. Therefore, we treated dyslipidemia patients with Chunghyul-plus. Before treatment, patients' levels of total cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), and LDL-C were measured on an empty stomach. Thereafter, patients were administered 1000 mg (2 capsules) of Chunghyul-plus two or three times a day for 2 weeks. After treatment with Chunghyul-plus, patients' serum triglyceride, LDL-C, and total cholesterol levels decreased. The results of this study suggest that Chunghyul-plus might be useful in the treatment of dyslipidemia.

Keywords